title: Blocking the expression of the hepatitis B virus S gene in hepatocellular carcinoma cell lines with an anti-gene locked nucleic acid in vitro.
abstract: The aim of this study was to investigate the effects of inhibition of the hepatitis B virus (HBV) S gene by polypurine region locked nucleic acid on viral replication in cells. We designed and synthesized a locked nucleic acid, phosphorothioate oligonucleotides, unmodified oligonucleotides, and unrelated control sequence for the hepatitis B virus S gene polypurine region. HepG2.2.15 cells were transfected by cationic liposome, and fluorescence quantitative polymerase chain reaction technology (PCR) and time-resolved fluoroimmunoassay technology was utilized to monitor the content of HBV DNA, HbsAg, and HBeAg at 2, 4, 6, 8 and 10 days post-transfection. The effects on cell metabolism were detected by four methyl thiazolyl tetrazolium assay. The locked nucleic acid had an obvious effect on HBV DNA replication and HBsAg and HBeAg expression in a dose and time dependent man-ner. The inhibition rates were 52.14, 57.48, and 29.63% after 6 days, respectively. The locked nucleic acid had no significant effect on cell metabolism. The HBV S gene polypurine region locked nucleic acid could effectively inhibit the replication of HBV in vitro, and could provide an effective target for the treatment of HBV and a theoretical and experimental basis for anti-gene therapy.
authors.affiliation: Medical Examination Center of the Affiliated Hospital of Youjiang Nationalities Medical College, Guangxi Province Baise City, China dengyb75@163.com.
authors.forename: Y-B
authors.initials: YB
authors.lastname: Deng
authors.affiliation: Medical Examination Center of the Affiliated Hospital of Youjiang Nationalities Medical College, Guangxi Province Baise City, China.
authors.forename: H-J
authors.initials: HJ
authors.lastname: Qin
authors.affiliation: Medical Examination Center of the Affiliated Hospital of Youjiang Nationalities Medical College, Guangxi Province Baise City, China.
authors.forename: Y-H
authors.initials: YH
authors.lastname: Luo
authors.affiliation: Medical Examination Center of the Affiliated Hospital of Youjiang Nationalities Medical College, Guangxi Province Baise City, China.
authors.forename: Z-R
authors.initials: ZR
authors.lastname: Liang
authors.affiliation: Medical Examination Center of the Affiliated Hospital of Youjiang Nationalities Medical College, Guangxi Province Baise City, China.
authors.forename: J-J
authors.initials: JJ
authors.lastname: Zou
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D004261:DNA Replication / Q000187:drug effects; D004279:DNA, Viral / Q000235:genetics; D015967:Gene Expression Regulation, Viral; D015316:Genetic Therapy; D056945:Hep G2 Cells; D006515:Hepatitis B virus / Q000187:drug effects / Q000235:genetics / Q000472:pathogenicity; D006801:Humans; D008113:Liver Neoplasms / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D009841:Oligonucleotides / Q000008:administration & dosage / Q000235:genetics*; D014759:Viral Envelope Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000235:genetics
chemical_list: D004279:DNA, Viral; D009841:Oligonucleotides; C118669:S envelope protein, hepatitis B virus; D014759:Viral Envelope Proteins; C477371:locked nucleic acid